The University of Chicago Header Logo

Systemic hypertension after intravitreal bevacizumab therapy for type 1 ROP: is there evidence for concern?


Collapse Biography 

Collapse Time 
Collapse start date
2020-07-01
Collapse end date
2021-06-30